Icosapent Disease Interactions
There are 3 disease interactions with icosapent.
Icosapent (applies to icosapent) atrial fibrillation/flutter
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Arrhythmias
Icosapent is associated with an increased risk of atrial fibrillation or atrial flutter requiring hospitalization. In a cardiovascular outcomes trial, the incidence of atrial fibrillation was greater in patients with history of atrial fibrillation or atrial flutter; caution is recommended in these patients.
Icosapent (applies to icosapent) fish allergy
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Allergies
Icosapent ethyl is obtained from the oil of fish. It is unknown if patients with allergies to fish and/or shellfish are at increased risk of an allergic reaction to this drug. Use with caution in patients with known hypersensitivity to fish and/or shellfish; advise such patients about the potential for allergic reactions to this drug.
Icosapent (applies to icosapent) liver disease
Moderate Potential Hazard, Moderate plausibility.
In patients with liver dysfunction, ALT and AST levels should be monitored periodically during therapy with icosapent; caution is recommended in these patients.
Switch to professional interaction data
Icosapent drug interactions
There are 76 drug interactions with icosapent.
More about icosapent
- icosapent consumer information
- Check interactions
- Compare alternatives
- Reviews (125)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.